Ascendis Pharma
ASND
ASND
182 hedge funds and large institutions have $7.29B invested in Ascendis Pharma in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12.88% more ownership
Funds ownership: 110.98% → 123.86% (+13%)
9% more funds holding
Funds holding: 167 → 182 (+15)
7% more funds holding in top 10
Funds holding in top 10: 15 → 16 (+1)
Holders
182
Holding in Top 10
16
Calls
$225M
Puts
$20.5M
Top Buyers
| 1 | +$394M | |
| 2 | +$82.6M | |
| 3 | +$59.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$39.7M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$36.1M |
Top Sellers
| 1 | -$133M | |
| 2 | -$47.3M | |
| 3 | -$33.4M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$25.7M |
| 5 |
SCM
Spyglass Capital Management
San Francisco,
California
|
-$16.5M |